Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

National Institutes of Health

Federal funding opportunity RFA-DA-26-034 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.